Keyphrases
Immune Response
100%
Elderly People
100%
Universal Vaccine
100%
Multimeric-001
100%
Cellular Immunity
33%
Hemagglutination Inhibition
33%
Placebo
25%
Trivalent Inactivated Influenza Vaccine
25%
Influenza
16%
Non-adjuvanted
16%
Vaccination
8%
Immunization
8%
Statistical Analysis
8%
Immune System
8%
Antibody Titer
8%
Randomized Placebo-controlled Trial
8%
Seroconversion
8%
Vaccine Strain
8%
Epitope
8%
Influenza B
8%
Influenza A
8%
Immunological Response
8%
Two-center
8%
Next-generation Vaccines
8%
Intramuscular Injection
8%
Direct Action
8%
Seasonal Influenza Vaccine
8%
Adjuvanted
8%
Saline Injection
8%
Small Populations
8%
Over 65
8%
Inhibition Response
8%
Multiple Strains
8%
Visible Difference
8%
Elderly Participants
8%
Medicine and Dentistry
Influenza Vaccine
100%
Elderly Population
100%
Immune Response
100%
Hemagglutinin
23%
Cellular Immunity
23%
Placebo
17%
Immune System
5%
Clinical Study
5%
Table Salt
5%
Arm
5%
Seroconversion
5%
Placebo-Controlled Study
5%
Vaccine Strain
5%
Influenza B
5%
Influenza A
5%
Epitope
5%
Intramuscular Injection
5%
Population Size
5%
Biochemistry, Genetics and Molecular Biology
Hemagglutinin
100%
Immune Response
100%
Cellular Immunity
100%
Titer
25%
Sample Size
25%
Seroconversion
25%
Clinical Study
25%
Population Size
25%
Immunology and Microbiology
Immune Response
100%
Influenza Vaccine
100%
Adoptive Immunity
23%
Hemagglutinin
23%
Influenza
17%
Immune System
5%
Arm
5%
Antibody Titer
5%
Sample Size
5%
Seroconversion
5%
Epitope
5%
Population Size
5%
Pharmacology, Toxicology and Pharmaceutical Science
Live Attenuated Influenza Vaccine
100%
Hemagglutinin
23%
Placebo
17%
Clinical Study
5%
Table Salt
5%
Placebo-Controlled Study
5%
Influenza A
5%
Influenza B
5%
Epitope
5%
Intramuscular Injection
5%
Vaccine Strain
5%